Significant upregulation of tissue and blood ANG2 levels has been reported in many cancer types including melanoma, glioblastoma, breast cancer, renal cell carcinoma (RCC) and colorectal cancer and its expression is strongly associated with that of VEGF in angiogenesis and tumor progression [54,55]. The gene discussed is VEGFA; the disease is renal cell carcinoma.